Phase I result of ICP-192 (gunagratinib), a highly selective irreversible FGFR inhibitor, in patients with advanced solid tumors harboring FGFR pathway alterations. This is an ASCO Meeting Abstract ...
A new study published in Research describes a deep-learning system designed to assist lumbar spine MRI at the point of image ...
Results from the PRECISION trial (Efficacy and Safety Outcomes of Radial- vs Femoral-Access Robotic Percutaneous Coronary Intervention: Final Results of the Multicenter PRECISION Registry) were ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results